- Home
- BSTZ vs SUPN Comparison
BSTZ vs SUPN Comparison
Compare BSTZ & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- SUPN
- Stock Information
- Founded
- BSTZ 2019
- SUPN 2005
- Country
- BSTZ United States
- SUPN United States
- Employees
- BSTZ N/A
- SUPN N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- BSTZ Finance
- SUPN Health Care
- Exchange
- BSTZ Nasdaq
- SUPN Nasdaq
- Market Cap
- BSTZ 1.6B
- SUPN 1.7B
- IPO Year
- BSTZ N/A
- SUPN 2012
- Fundamental
- Price
- BSTZ $18.21
- SUPN $32.82
- Analyst Decision
- BSTZ
- SUPN Hold
- Analyst Count
- BSTZ 0
- SUPN 2
- Target Price
- BSTZ N/A
- SUPN $36.00
- AVG Volume (30 Days)
- BSTZ 303.2K
- SUPN 634.8K
- Earning Date
- BSTZ 01-01-0001
- SUPN 05-07-2025
- Dividend Yield
- BSTZ 8.31%
- SUPN N/A
- EPS Growth
- BSTZ N/A
- SUPN 6500.00
- EPS
- BSTZ 0.71
- SUPN 1.32
- Revenue
- BSTZ N/A
- SUPN $661,817,000.00
- Revenue This Year
- BSTZ N/A
- SUPN N/A
- Revenue Next Year
- BSTZ N/A
- SUPN $9.32
- P/E Ratio
- BSTZ $26.69
- SUPN $24.50
- Revenue Growth
- BSTZ N/A
- SUPN 8.94
- 52 Week Low
- BSTZ $14.11
- SUPN $25.53
- 52 Week High
- BSTZ $19.43
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- BSTZ 38.84
- SUPN 49.41
- Support Level
- BSTZ $17.63
- SUPN $31.74
- Resistance Level
- BSTZ $19.35
- SUPN $32.87
- Average True Range (ATR)
- BSTZ 0.35
- SUPN 1.00
- MACD
- BSTZ 0.02
- SUPN 0.23
- Stochastic Oscillator
- BSTZ 33.66
- SUPN 71.76
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.